Oncolytics Biotech Inc T.ONC

Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed

[Jonathon Brown]

A highlight of the week was Bombardier (TSX:BBD), which reported impressive growth in its Q3 2024 results. read article.

[Noteable]

Chris Boshoff is personally familiar working with ONCY and has Pfizer has developed the SC delivered PD-1 checkpoint inhibitor sasanlimab that can benefit from the addition of ONCY's IV delivered&

[Noteable]

Whoever acquires pelareorep will brand the drug with a new trade name for commercialization, and the brand name Reolysin is no longer relevant.

[Noteable]

The expired patents have established prior art and there was no good reason to have extended them. Meanwhile the composition of matter is extendable to 2031 and the new patents will further protect

[inthno]

Hello and curious as to why the patents have not been extended rather than repeating that  they can be extended. Would it not be easier to just extend them now and remove all doubt such as maybe

[settoretire]

No, you're mistaken. What I mean is, one set of governance is for the people, by the people. The other is, do as I say, not as I do. There is a definite distinction between the two.

[Noteable]

Title: LIQUID VIRAL FORMULATIONS Issued on 2023-04-25  Effective until : 2031-12-02

[Noteable]

Title : IMPROVEMENT IN VIRAL EXTRACTION FROM CELL CULTURE

[Buckhenry]

Oncy accelerated approval... lmfao

[Noteable]

Should read: ONCY's original composition of matter patent on pelareorep can be extended until 2031, while ONCY's modified non-reovirus (pelareorep) virus comprising a reovirus sigma-1 protein

[Peladawn]

Hey Quentin....better bash a little harder.....you certainly wouldn't want Pela to get accelerated approval and give hope to all the people suffering and dying from metastatic breast and

[Noteable]

To further clarify, the FDA provides a novel biologic drug 13 years of market exclusivity from the date of approval, independent of patent status, AND a confirmatory trial is run AFTER the FDA

[Quentin30]

Must be a BUYING opporuntity again eh Canaduh... how many is that now over the past 25 years... How much do you think ONCY will be worth when the key patents expire... More than now, or less than now

[Buckhenry]

Just think if we had bought 1000 shares of tesla..nvda..Netflix..meta...Google  5 years ago instead of getting stuck with this POS... oh my...

[Noteable]

Pfizer’s Oncology R&D organization will maintain its fully integrated structure with Roger Dansey, M.D. serving as Interim Chief Oncology Officer, reporting to Dr. Boshoff effective January 1

[Noteable]

November 20, 2024 - Chris Boshoff will take over the role of chief scientific officer and president of research and development as of January 1, 2025. He rises from his position as chief oncology